david: It all boils down to getting the facility built and approved. Once that happens the company has the potential to secure a nice government grant for the brucellosis vaccine for cattle. That is just the kind of orphan type type product the government could possibly fund, because the potential profit might not be sufficient for private enterprise to develop it on its own. More important than government grants would be the potential for plasmid sales to other vaccine makers like PowderMed/Pfizer, Vical and others. Malcolm and Dr. Chen need to do the rounds next year and try to present synDNA at every DNA Vaccine and related conference being held anywhere in the world. There are quite a few such conferences, starting in Baltimore in January. Market, market, market.....Get the DNA Therapeutics community fully aware of synDNA, its purity, effectiveness and potential cost savings. Malcolm and Dr. Chen need to develop relationships in the industry that can result in significant business down the road. We can't expect GE and Aldevron to carry all our water. CYGX has not done a good job in the past with this avenue of promotion, but they need to start this year in anticipation of the facility. Once built, the new facility will have tremendous capacity for Plasmid manufacture, up to 50 grams a day. We need to generate interest in synDNA Plasmids so that we can utilize that production capacity to generate the potentially enormous profits we all hope for.
News 
Market Data 
Discover 
